Guardant360® Liquid is the first and only comprehensive liquid biopsy to deliver genomic and epigenomic insights in a single blood test. Powered by the GuardantINFINITY™ platform, it provides a deeper, multi-dimensional view of cancer biology—helping clinicians make more confident, timely treatment decisions.
Download Brochures: Information Sheet, Gene Panel
Comprehensive insights in one test
Analyse 740+ genomic biomarkers alongside 19,000+ epigenomic signals from a single blood draw.
High sensitivity
Detect variants at levels as low as 0.001% mutant allele fraction (MAF).
Fast turnaround time
Results available in as little as 7 days.
Future-ready testing
Continuous feature updates at no extra cost.
GuardantINFINITY™ enables a multi-dimensional view of cancer, expanded treatment options, and continuous innovation in one revolutionary test.
Product availability may vary by region. Guardant360® Liquid is a laboratory-developed test (LDT) and is not approved or marketed in the EU. Performance characteristics are determined by Guardant Health’s CLIA-certified laboratory.
Original: $5,778.27
-70%$5,778.27
$1,733.48Product Information
Shipping & Returns
Guardant360® Liquid is the first and only comprehensive liquid biopsy to deliver genomic and epigenomic insights in a single blood test. Powered by the GuardantINFINITY™ platform, it provides a deeper, multi-dimensional view of cancer biology—helping clinicians make more confident, timely treatment decisions.
Download Brochures: Information Sheet, Gene Panel
Comprehensive insights in one test
Analyse 740+ genomic biomarkers alongside 19,000+ epigenomic signals from a single blood draw.
High sensitivity
Detect variants at levels as low as 0.001% mutant allele fraction (MAF).
Fast turnaround time
Results available in as little as 7 days.
Future-ready testing
Continuous feature updates at no extra cost.
GuardantINFINITY™ enables a multi-dimensional view of cancer, expanded treatment options, and continuous innovation in one revolutionary test.
Product availability may vary by region. Guardant360® Liquid is a laboratory-developed test (LDT) and is not approved or marketed in the EU. Performance characteristics are determined by Guardant Health’s CLIA-certified laboratory.
Original: $5,778.27
-70%$5,778.27
$1,733.48
